Stock Overview
Natera Inc (NTRA)
NASDAQ · Healthcare · Diagnostics & Research
Natera Inc is a Healthcare company with a market capitalization of $37.51B.
Market Cap
$37.51B
Price/Sales
15.0
Price/Book
21.1
EV/EBITDA
-26.8
Beta
1.54
EPS (TTM)
$-1.62
Profit Margin
-9.0%
ROE
-15.0%
52W High
$271.47
52W Low
$131.81
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Revenue
$2.31B
Gross Profit
$1.50B
Operating Income
-$309.91M
Net Income
-$208.16M
Free Cash Flow
$109.11M
Total Debt
$95.90M
Cash & Equivalents
$1.08B
Shareholder Equity
$1.71B
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 7, 2026 | $-0.60 | $-0.55 | -9.1% |
| Q4 2025 | February 26, 2026 | $0.36 | $-0.50 | +172.0% |
| Q3 2025 | November 6, 2025 | $-0.64 | $-0.35 | -82.9% |
| Q2 2025 | August 7, 2025 | $-0.74 | $-0.59 | -25.4% |
| Q1 2025 | May 8, 2025 | $-0.50 | $-0.66 | +24.2% |
| Q4 2024 | February 27, 2025 | $-0.41 | $-0.35 | -18.3% |
Other Diagnostics & Research Stocks
Frequently Asked Questions
What is Natera Inc's market cap?
As of June 29, 2026, Natera Inc (NTRA) has a market capitalization of $37.51B.
Does Natera Inc pay a dividend?
Natera Inc does not currently pay a dividend.
What sector is NTRA in?
Natera Inc is in the Healthcare sector, specifically the Diagnostics & Research industry.
What was Natera Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Natera Inc reported revenue of $2.31B and net income of -$208.16M.
Ask your own questions about NTRA
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.